EZH2 promotes proliferation and invasiveness of prostate cancer cells

Citations Over TimeTop 10% of 2007 papers

Abstract

Abstract BACKGROUND The transcriptional repressor EZH2 is implicated in control of cell proliferation in embryonic, immortalized and transformed cells. EZH2 expression in prostate cancer correlates with progression to hormone‐refractory and metastatic disease, but it is unknown whether EZH2 plays a specific role in the acquisition of an advanced prostate cancer phenotype. METHODS Using siRNA knockdown, we investigated the role of EZH2 in maintenance of prostate cancer cell proliferation and invasiveness. Using LNCaP cells with inducible EZH2 overexpression, we investigated whether EZH2 upregulation promotes an aggressive phenotype. RESULTS Knockdown of endogenous EZH2 reduced proliferation of androgen‐responsive and androgen‐independent prostate cancer cells. EZH2 knockdown also inhibited prostate cancer cell invasion. However, overexpression of EZH2 in androgen‐responsive cancer cells did not appreciably affect either proliferation or invasiveness. CONCLUSIONS EZH2 promotes proliferation and invasion of prostate cancer cells, which can account for the correlation between EZH2 expression levels and an adverse prostate cancer prognosis. Prostate 67: 547–556, 2007. © 2007 Wiley‐Liss, Inc.

Related Papers

• → Characterization of a novel metastatic prostate cancer cell line of LNCaP origin(2015)28 cited
• → Use of a hormone-sensitive (LNCaP) and a hormone-resistant (LNCaP-r) cell line in prostate cancer research(1997)20 cited
• Inhibitive effect of androgen receptor antisense RNA on tumorigenesis of human prostate cancer cell LNCaP(2003)
• Establishment of androgen-independent human prostate cancer cell line model LNCaP-AI(2008)
• → Use of a hormone‐sensitive (LNCaP) and a hormone‐resistant (LNCaP‐r) cell line in prostate cancer research(1997)